Sotac Pharmaceuticals Limited Financial Ratios
SOTAC · Healthcare · Current price ₹90.05
P/E ratio
17.3x
P/B ratio
1.7x
ROE
9.8%
ROCE
13.3%
Debt / Equity
0.64
Dividend yield
0.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 17.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 9.8% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 13.3% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.64 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Sotac Pharmaceuticals Limited's latest numbers.
Sotac Pharmaceuticals Limited profitability
Sotac Pharmaceuticals Limited generates a return on equity of 9.8% and a return on capital employed of 13.3%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.64 and a P/E of 17.3x, Sotac Pharmaceuticals Limited is moderately leveraged. Our overall business-quality score for the company is 5.2 / 10.
Understand the ratios
More on Sotac Pharmaceuticals Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.